DocGo Inc. Gain (Loss) on Disposition of Assets
DocGo Inc. (DCGO) reported Gain (Loss) on Disposition of Assets of -$39.57 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-17
- DocGo Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was -$39.57K.
- DocGo Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was -$62.49K, a 512.79% decline year-over-year.
- DocGo Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $4.00K.
- DocGo Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was -$10.45K.
- DocGo Inc. gain (loss) on disposition of assets for fiscal 2025 was -$39.67K, a 259.02% decline from fiscal 2024.
- DocGo Inc. gain (loss) on disposition of assets for fiscal 2024 was $24.95K.
- DocGo Inc. gain (loss) on disposition of assets for fiscal 2023 was -$852.54K.
- DocGo Inc. gain (loss) on disposition of assets for fiscal 2022 was -$21.17K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$39.57K 10-Q · filed 2026-08-17 | -$102.07K 10-Q · filed 2026-08-17 | -$98.07K derived: sum of 3 quarters · filed 2026-08-17 | -$108.52K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$62.49K 10-Q · filed 2026-05-11 | -$58.49K derived: sum of 2 quarters · filed 2026-05-11 | -$68.95K derived: sum of 3 quarters · filed 2026-05-11 | -$117.30K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$6.45K derived: sum of 2 quarters · filed 2026-03-16 | -$54.81K derived: sum of 3 quarters · filed 2026-08-17 | -$39.67K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$10.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$58.81K derived: sum of 2 quarters · filed 2026-08-17 | -$43.67K 10-Q · filed 2025-11-10 | -$56.70K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$48.35K 10-Q · filed 2026-08-17 | -$33.22K 10-Q · filed 2026-08-17 | -$46.25K derived: sum of 3 quarters · filed 2026-08-17 | |
| 2025-03-31 | $15.14K 10-Q · filed 2026-05-11 | $2.10K derived: sum of 2 quarters · filed 2026-05-11 | ||
| 2024-12-31 | -$13.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $24.95K 10-K · filed 2026-03-16 | ||
| 2024-09-30 | $37.98K 10-Q · filed 2024-11-07 | |||
| 2023-12-31 | -$852.54K 10-K · filed 2026-03-16 | |||
| 2023-03-31 | -$54.84K 10-Q · filed 2023-05-09 | -$118.68K derived: sum of 2 quarters · filed 2025-02-27 | -$76.01K derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$63.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$21.17K derived: sum of 2 quarters · filed 2025-02-27 | -$21.17K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $42.67K 10-Q · filed 2022-11-08 | $42.67K 10-Q · filed 2022-11-08 | ||
| 2021-12-31 | -$6.61K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$6.61K derived: sum of 2 quarters · filed 2023-03-14 | -$34.34K derived: sum of 3 quarters · filed 2023-03-14 | -$34.34K 10-K · filed 2023-03-14 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$27.73K derived: sum of 2 quarters · filed 2022-11-08 | -$27.73K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$27.73K 10-Q · filed 2022-08-09 | -$27.73K 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | $30.55K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |